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ABSTRACT
The incidence of diabetes is predicted to increase to 21% by 2050. Currently, one third of US
adults are obese and over 11% of these individuals have diabetes. Due to the growing need
for therapeutic intervention to control and/or
stabilize this increase in the incidence of diabetes in Western communities, gaining a comprehensive understanding of the association between obesity and Type 2 diabetes has become
increasingly important to diabetes research. The
increased cell senescence associated with diabetes has been associated with the limited ability of cells to divide, with indication of telomere
shortening and genomic instability of the cells.
Obese individuals have shorter telomeres suggesting an inverse relationship between adiposity and telomere length. The implication that
Type 2 diabetes has on biological aging is of
particular interest since telomere shortening in
obesity and diabetes has been associated with
an early risk for dementia and even progression
to Alzheimer’s disease (AD). Lifestyle, nutrition
and longevity are closely related and cellular
senescence has been associated with telomere
shortening and connected to longevity. Diet,
cholesterol lowering drugs and exercise that
control food intake and glucose tolerance in
aging and diabetic individuals, via connections
between liver circadian clocks and the suprachiasmatic nucleus in the brain, also have
been shown to alter telomere lengths. Lifestyle
interventions, such as diets low in fat and exercise, target the rise in obesity and associated
Copyright © 2013 SciRes.

telomere shortening by delaying or preventing
the onset of Type 2 diabetes. The implementation of these anti-aging therapies early in life
may prevent calorie overload and activation of
calorie sensitive genes such as Sirtuin 1 (Sirt1).
This may maintain telomere length and the control of obesity, which is linked to cardiovascular
disease, diabetes and accelerates aging and AD.
Keywords: Telomere; Sirtuin 1; Lifestyle; Nutrition;
Diabetes; Obesity; Alzheimer’s Disease

1. BACKGROUND
Age-related diseases are becoming a major concern as
the world’s population grows older due to advances in
medical technology, health and nutrition. Dementia accounts for a large proportion of age-related diseases and
is characterised clinically by deterioration in cognitive
processing, including memory. Alzheimer’s disease (AD)
is the most common form of age-related dementia. The
insulin-resistance syndrome has in many studies been
associated with diabetes and AD. The social and economic consequences of this disease present a significant
challenge to society, and it is imperative that strategies to
prevent or delay the onset of diabetes are developed to
prevent the proportion of the age related group with cardiovascular dysfunction progressing towards AD. AD is
a neurodegenerative disease which presents clinically
with key clinical symptoms including progressive decline in memory. Risk factors for AD include old age,
family history of dementia, APOE 4 genotype, Down’s
syndrome, obesity and type 2 diabetes.
Openly accessible at http://www.scirp.org/journal/health/
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Epidemiological studies clearly suggest that human
obesity is associated with the increased risk for atherosclerosis, contributing to the early onset of coronary artery disease and diabetes. The susceptibility of humans to
obesity is far higher compared with other species [1].
Amongst mammals, humans have been reported to have
the highest level of fat than any other species as genes
and environmental factors predispose humans to obesity
[2]. In an editorial by Testa and Ceriello published in
2007, the increased cell senescence associated with
diabetes was associated with the limited ability of cells to
divide with indication of cellular alteration in genes and
genomic instability of the cells [3]. Human obesity may
complete the pathogenetic loop between cell senescence
and diabetes through teleomere shortening and an association with an increased risk for atherosclerosis. This in
turn contributes to the early onset of coronary artery disease and diabetes.
Visceral obesity in particular increases the risk of
atherosclerosis owing to both insulin resistance and
dyslipoproteinemia and this global rise in obesity is possibly linked to telomere disease. Obesity has been closely
linked to diabetes [4,5] and the association of obesity and
telomere shortening has now been reported [6]. In particular, telomere length, high density lipoprotein (HDL)
cholesterol [7] and other risk factors for atherosclerosis
that could be exacerbated by obesity-associated telomere
dysfunction include hypertension and hyperlipidemia
(particularly hypertriglyceridemia). These are also risk
factors for AD. Circadian desynchrony and hyperphagia
are also related to obesity and anti-aging, circadian
proteins, such as sirtuins are known to regulate several
cell functions by deacetylating both histone and nonhisotone targets. Sirtuins are NAD(+)dependent class III
histone deacetylase (HDAC) proteins that target transcription factors to adapt gene expression to metabolic
activity. Sirtuin 1 (Sirt1) is linked to life span, obesity
and cardiovascular disease with effects on liver steatosis,
inflammation, food intake, energy metabolism, cognition,
mitochondrial biogenesis, neurogenesis, glucose/cholesterol metabolism and amyloidosis [8-22]. Regulation of
Sirt1 by calorie restriction in extending life span has
been recognized. Novel dietary acitvators of Sirt1 are
required and designing compounds that have therapeutic
potential for the control of telomere shortening, clock
circuitry and generation of Aβ for the treatment of AD is
the focus of several research groups [23-26].
Obesity in humans is seen to be associated with decreased life span in man and is an excellent model for the
assessment of cell senescence, inflammation, diabetes
and AD [27-31]. The understanding of alterations in
genes/genomic stability and the environment in the aging
brain has been the subject of various anti-aging programs
as well as the mechanisms involved in anti-aging strateCopyright © 2013 SciRes.

gies related to low fat diets and reversing brain aging.
The association between diabetes and neurodegenerative
diseases (AD and Parkinson’s disease) have related the
majority of the genes to cholesterol metabolism, cytokines and inflammation. Environmental factors such as
diet and circadian desynchrony have become important
in Western countries since interests in the global increase
in obesity is possbily linked to diabetes, timing of food
consumption, metabolic activity and alterations in adipose tissue leading to a release of adipokines (leptin and
adiponectin). These adipokines increase with age and are
associated with age related pathological alterations in
cytokines associated with neuroinflammation [32,33].

2. CONVERGENCE OF MECHANISMS
LINKING OBESITY TO DIABETES AND
ACCELERATION OF AGING AND
ALZHEIMER’S DISEASE
The mechanism linking obesity with diabetes is unclear but the global epidemic indicates that most patients
with type 2 diabetes are obese; over a third (34%) of US
adults are obese and about 11% of these individuals have
diabetes [4]. The incidence of diabetes is predicated to
increase to 21% by 2050 [5]. The understanding of
mechanisms which connects these two diseases has become important to diabetes research since therapeutics to
control and stabilize the increase in the incidence of diabetes in Western communities is required. As lipids and
proteins accumulate in cells, the cells become impaired
and can no longer divide, decreasing the lifespan of the
cell resulting in cell telomeres that have eroded or shortened with cell senescence. The telomere is a repeating
sequence of DNA at the end of a chromosome
(TTAGGG)n [34,35]. Aging results in a progressive loss
of telomere repeats and with telomere shortening the cell
ceases to replicate with alterations in lipid and protein
metabolism with eventual cell death [34,35]. Obese individuals have shorter telomeres and an inverse relationship has been found with adiposity and telomere length
[6,36,37]. The pathogenetic loop between obesity and
diabetes has recently been related to Sirt1 which is involved in cellular senescence. The genomic instability
and telomere dysfunction observed in obesity is now
closely associated with the pathogenesis of diabetes,
dyslipidemia and cardiovascular disease. Diabetes, genetic and environmental factors have been reported to
stress telomeres [38] through telomere shortening (Figure 1).
Sirt1 and cell senescence has been closely linked to
telomere biology and global DNA repair which provides
mechanistic explanations for SIRT1 functions, in protection from DNA damage, and thus genomic stability
[39,40]. Sirt1 has been closely linked to telomerase
which is a ribonucleoprotein (RNP) complex responsible
Openly accessible at http://www.scirp.org/journal/health/
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erase is of interest to diabetes and AD with recent publiccations suggesting telomerase inhibition is involved with
abeta cell apoptosis. In AD, transgenic mice telomere
length has also shown to be associated with amyloid pathology with indications that Sirt1 expression and activity is essential to neuronal population maintenance and
prevention of AD.
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Figure 1. Nutrition, lifestyle and aging determine telomerelength and genomic stability.

for the elongation of telomeres to maintain genomic integrity. Telomerase is composed of the telomerase reverse transcriptase (TERT) and telomerase RNA components (TERC). These factors regulate the catalytic activity of telomerase [41]. Telomerase protects cells from
apoptosis via the maintenance of genomic integrity by
stabilizing telomeres and adding DNA, in mediating cell
survival and anti-apoptotic functions against various cytotoxic stresses [42,43]. Telomerase is closely connected
to telomere length maintenance and control of genes involved in growth and cell proliferation [44].
Anti-aging strategies that target telomere shortening in
diabetes is of particular interest to biological aging since
telomere shortening has been associated as an early risk
for dementia [45,46]. Age-related changes in AD lead to
neuronal apoptosis and therapy to delay the onset and
even progression of Alzheimer’s disease are urgently
required. Nutrition related to low fat diets and drugs that
reduce intestinal absorption of fat with modulation of
adipose tissue Sirt1 activity may improve the adipocyte
brain crosstalk that may be assessed as a possible treatment of neuronal diseases that afflict diabetic and AD
individuals. Sirt1 is essential for neurogenesis and calorie restriction activates Sirt1 with effects on longevity by
modulation of phosphoinositide 3 kinase pathway that
determines life span [47-49]. The role of Sirt1 in brain
metabolic regulation and synaptic plasticity has been
shown and maintenance of Sirt1 expression by calorie
restriction regulates lipid metabolism and energy expenditure [19]. Age associated cardiovascular changes have
been strongly associated with alterations in Sirt1 [8-11]
and genetic as well as experimental evidence of its control of lifespan is of interest to the areas of diabetes,
neurodegeneration and AD. Telomere and telomerase
activity has now taken an important place in AD therapeutics, using telomere length and telomerase activity in
the determination of neuronal populations in these individuals [50,51]. Sirt1 and its role in AD is of interest
with reviews that indicate that Sirt1 is closely connected
to Abeta production, telomere maintenance and stem cell
aging [39,40,52,53]. Interests in Sirt1 control of telomCopyright © 2013 SciRes.

3. LIFESTYLE, DIET AND DRUG
CONNECTIONS TO DIABETES AND
ALZHEIMER’S DISEASE
The estimate in global deaths due to diabetes was estimated to be 5.2% of all deaths in 2009 [54]. In poorer
countries, mortality related to diabetes was 2% - 3%, in
countries such as the USA, Canada and the middle east
the mortality was approx. 8% and for individuals between 35 - 64 years between 6% - 27% of the deaths
were attributable to diabetes [55]. In 2011, the largest
number of people with diabetes were in India, China,
United States of America and the Russian Federation and
mortality in 2011 reached 8.2% of the global population
[55] Nutrition and longevity are closely related and cellular senescence has been associated with telomere
shortening as well as the life span of the organism
[34,35]. Apart from nutrition, minor alcohol consumption
has been shown in midlife to shorten telomeres and accelerate aging in older individuals [56,57]. Diet, cholesterol lowering drugs and exercise may improve telomere
lengths. This may provide the classical evolutionary
conserved environment to suit anti-inflammatory processes which control of food intake and circadian rhythm
and promote normal liver and brain, lipid and protein
homeostasis, ultimately preventing glucose intolerance
and diabetes.
Sirt1 (nutrient sensitive gene) is closely linked to food
intake and the prevention of diabetes, which is linked to
amyloidosis and may offer a potential therapy for AD
treatment (Figure 2, [58,59]). Interests in high fat intake
and the consumption of fat at specific times of the day
requires further investigation as a mechanism for diabetes and AD induction. Drugs that reduce intestinal absorption of fat will modulate the tissue anti-aging protein
Sirt1, improving the adipocyte brain crosstalk that should
be assessed as a possible treatment of neuronal diseases
such as AD.
In recent years, the world diabetes epidemic now includes younger individuals and has become of concern
because of the risk for telomere shortening and non-alcoholic liver disease (NAFLD) [60]. In Western countries, accelerated aging is associated with NAFLD and
has reached epidemic levels, with 40 % of the community with the disease and up to 20% of these individuals
developing hepatic fibrosis and cirrhosis [61,62]. InOpenly accessible at http://www.scirp.org/journal/health/
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dividuals with longer lifespan have been shown to be
diabetes free and increased mortality was attributed to
increases in obesity [61]. Age related pathologies, such
as NAFLD, that have been linked to Type 2 diabetes and
AD, indicate association between insulin resistance, oxidative stress and telomere shortening [63]. Hepatocyte
senescence, telomere shortening, nuclear size alterations and telomere foci have been closely associated to
NAFLD and indicate mitochondrial dysfunction and lack
of cell cycle progression beyond the cell cycle G1/S
phase [64-68]. Interests in telomere shortening and insulin resistance indicate that the suprachiasmatic nucleus
(SCN), which closely regu- lates peripheral clocks such
as the liver (NAFLD) and adipose tissue (increased adiposity), is abnormal with relevance to the pathophysiology of disease [62] progression in obese, diabetic and
AD individuals [69-72].
Drug therapies that target the brain have not been
successful in preventing amyloid deposition but drugs
that target the periphery may be promising by lengthening peripheral cell telomeres, lowering plasma fat and
cholesterol and activating adipose tissue, liver and brain
metabolic activity. Interest in Sirt1 modulation of various
proteins that regulate cellular inflammation, glucose and
cholesterol homeostasis are relevant to diabetes and
neurodegeneration. Regulation of this calorie-restricted
gene, Sirt1, as an important control that targets obesity,
diabetes and brain aging by suppression of inflammation
as well as maintenance of neuroprotective mechanisms
that facilitate normal food intake and vitamin E transport
to the central nervous system essential for growth of
neurons has been the interest of anti-aging research studies. Designing compounds for the regulation of Sirt1 to
extend life span has been recognized and activators of
Sirt1 in order for telomere maintenance have been reported. The use of melatonin, which is involved in
telomere maintenace and circadian clock control [40], is
relevant for the treatment of diabetes and AD as compared
Copyright © 2013 SciRes.

with other circadian rhythm drugs such as the benzodiazepines or non-benzodiazepines.
The relationship between telomere erosion and apoE4
is closely associated [23] with the role of apolipoprotein
E and its connections with inflammation/cytokines [73,
74] as an important control of telomere attrition in the
periphery and the brain. The connections between dyslipidemia and inflammation have been reported in diabetes, where inflammation in the blood plasma and altered
cytokines have been associated with changes in lipid
metabolism (increased triglyceride and low HDL) and in
the brain, alterations in the light/dark cycle [75]. Drugs
involved with telomere lengthening are possibly involved in the adaptation of the organism to the environment and require regulation of liver glucose and cholesterol and are controlled by dietary fat and cholesterol
intake (Figure 2, [76-78]). The mechanism by which the
4 allele promotes AD risk could be associated with diabetes and telomere shortening as well as with abnormal
regulation of food intake, explaining the hyperphagia
associated changes in diabetes and AD [79-81].

4. NUTRITIONAL SCIENCE AND DRUGS
DELAY OBESITY AND SEVERITY OF
DIABETES LINKED TO AGING AND
ALZHEIMER’S DISEASE
Biological aging is closely connected to telomere
length and control of cellular senescence. Each time a
cell replicates and divides the telomere loses some of its
length. Eventually the telomere runs out and the cell can
no longer divide and rejuvenate, triggering a poor state
of cell health that contributes to disease risk and eventual
cell death. Telomere length is epigenetically regulated
and affected by nutrients, alcohol, drugs, genetics and the
environment (Figure 3). It is interesting to note that telomere shortening would be accelerated by synergistic
effects of mixing alcohol and fats such as palmitic acid
with increased genomic instability and DNA breakdown.
The effective function of telomeres require methylation,
which uses nutrients like methionine, an essential amino
acid that serves as a methyl donor and is involved with
the biosynthesis of other nutrients. Improper conversion
is associated with production of homocysteine and
atherosclerosis, methylsulfonylmethane, sulphur, choline,
and trimethylglycine, as building blocks and allow regulation of genes by appropriate telomeres. Vitamins such
as vitamin B12, folic acid, and vitamin B6 play multiple
roles in genomic stability as well. Foods that are important include protein, eggs, cottage cheese, dairy, red meat,
chicken, legumes, duck, nuts, and seeds. Antioxidants
and vitamins C, D and E are essential and maintain genomic stability as well as telomeres. A lack of antioxidants leads to increased free radical damage and more
risk for damage to telomeres. Minerals, such as magOpenly accessible at http://www.scirp.org/journal/health/
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eases such as obesity, diabetes, cardiovascular disease
and AD. Lifestyles changes such as diet and exercise
early in the life of obese or diabetic individuals may
prevent circadian alterations and calorie overload. Continued Sirt1 activation and the maintenance of peripheral
(liver) and CNS (brain) cell telomeres with prevention of
obesity linked to diabetes may decrease accelerated aging and the risk of AD.

5. CONCLUSION
Figure 3. Potential anti-aging therapies (left) delay the aging
process by telomere maintenance and control of DNA damage.

nesium, are needed by many enzymes involved with
DNA replication and repair and total magnesium intake
should be between 400 mg - 800 mg per day. Zinc is intimately involved with DNA as well as DNA repair. The
lack of zinc causes an excessive amount of DNA strand
breakage and telomere depletion. Inflammation and stress
shorten telomeres and omega 3 fatty acids (eicosapentaenoic acid/docosahexaenoic acid) are important as basic nutrients to preserve telomeres. Nutrients such as
quercetin, green tea catechins, grape seed extract, curcumin, and resveratrol also help maintain telomeres, with
both grape seed extract and curcumin showing the ability
to generate longer telomeres. In addition, resveratrol and
calorie restriction activate Sirt1 with prevention of telomere attrition.
Drug evaluation and differences in therapeutic effects
of various drugs may indicate that the telomere length of
tested rodents or diseased individuals may be related to
genetic, diet and environmental conditions. Drugs such
as statins have been shown to control telomere/telomerase in peripheral leukocytes from individuals with cardiovascular disease [82,83] and have provided potential
anti-aging therapy for diabetes and AD. Statins, however,
are not Sirt1 activators and Sirt1 activators are primarily
in control of telomere length and attrition. The close association of hyperphagia with diabetes and AD indicate
that fat consumption (calorie excess) may have marked
effects on telomeres/telomerase activation [42,43]. Experimental drugs in mice, such as an acyl coA cholesterol
acyltransferase (ACAT) inhibitor Avasimibe, that prevents fat absorption (calorie excess) have shown clear
effects on body weight, liver and brain growth in mice
consuming high fat diets (Abstract AD/PD Italy, 2013)
possibly as a Sirt1/telomerase activator. Interests in telomerase activation have increased with the recent findings of TA-65 (purified from the root of Astragalus
membranaceus/legume), a small molecule activator of
telomerase involved in glucose regulation [84]. In contrast, various drugs that are Sirt1 inhibitors should be
assessed with various diets since telomere shortening and
attrition by Sirt1 inhibitors will lead to degenerative disCopyright © 2013 SciRes.

The biological mechanism behind the global epidemic
of obesity and Type 2 diabetes has become important to
Alzheimer’s research since therapeutic interventions with
the potential to control and stabilize their increased incidence in Western society may also have the potential to
delay the acceleration in aging and AD. The increased
cell senescence associated with obesity and diabetes has
indicated an increase in telomere shortening and genomic
instability of the cells from these individuals. Stabilization of biological aging is of particular interest in obesity
and diabetes and the delay of telomere shortening in
these individuals may result in a decrease in dementia
and even a delay in the progression to (AD). Lifestyle,
nutrition and longevity are closely connected to life span
of obese and Type 2 diabetic individuals and therapeutics
such as cholesterol lowering drugs, exercise and diets
low in fat, target the rise in obesity and associated telomere shortening by delaying or preventing the onset of
Type 2 diabetes. Implementing these anti-aging therapies
early in life may prevent calorie overload and activation
of calorie sensitive genes, such as (Sirt1), that may maintain telomere length and the control of obesity, which is
linked to cardiovascular disease, diabetes and accelerates
aging and AD.
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